MSMarcus Semtner

Marcus Semtner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marcus Semtner has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Francesca Logiacco

    Cellular Neurosciences, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany

    4 shared publications
  • Helmut Kettenmann

    Cellular Neurosciences, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Germany

    4 shared publications
  • Helmut Kettenmann

    Cellular Neurosciences, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany

    3 shared publications
  • Jochen C. Meier

    Division Cell Physiology, Institute for Cell- and Neurobiology, Technical University Braunschweig

    3 shared publications
  • Philipp Mertins

    Proteomics Platform, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany

    2 shared publications
  • A Winkelmann

    RNA Editing and Hyperexcitability Disorders Helmholtz Group, Max Delbrück Center for Molecular Medicine, Berlin 13125, Germany

    1 shared publication

Latest Publications

  • Open Access

    Diversity of glutamate receptors in glial cells of the mouse optic nerve

    by Nine F. Kompier, Marcus Semtner, Sophie Walter, Christian Steinhäuser, Christiane Nolte, Helmut Kettenmann

    Introduction: Glial cells in the optic nerve express ionotropic glutamate receptors that may contribute to axon–glia communication, yet their functional expression in defined glial populations remains incompletely characterized. We investigated glutamate receptor-mediated responses in identified NG2 glia and astrocytes of the mouse optic nerve. Methods: We used a longitudinal optic nerve slice preparation combined with whole-cell patch-clamp recordings. NG2 glia and astrocytes were identified and electrophysiologically characterized using the transgenic reporter mouse lines hGFAP-eGFP and Cx43-ki-eCFP, respectively. Functional responses to kainic acid (KA), activating AMPA/kainate receptors, and NMDA were assessed at the single-cell level. Results: KA evoked membrane current responses in the majority of NG2 glia, whereas NMDA responses were restricted to a smaller subset and were associated with the absence of A-type K+ currents. In passive astrocytes, approximately half of the cells responded to KA and NMDA. KA responses showed heterogeneous current patterns, including increased cationic conductance and, in a subset of cells, reduced outward K+ currents, whereas NMDA responses were comparatively homogeneous. Discussion: These findings demonstrate substantial functional heterogeneity of ionotropic glutamate receptor responses within established optic nerve glial populations. Glutamate responsiveness does not define distinct glial cell types but rather represents an additional functional feature within NG2 glia and astrocytes. This diversity may enable glial cells to adapt to local neuronal activity and contribute to axon–glia communication and white matter homeostasis.

  • Open Access

    Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic

    by Francesca Logiacco, Laura Cathleen Grzegorzek, Elizabeth C. Cordell, Oliver Popp, Philipp Mertins, David H. Gutmann, Helmut Kettenmann, Marcus Semtner

    We previously discovered a sex-by-genotype defect in microglia function using a heterozygous germline knockout mouse model of Neurofibromatosis type 1 (Nf1 ± mice), in which only microglia from male Nf1 ± mice exhibited defects in purinergic signaling. Herein, we leveraged an unbiased proteomic approach to demonstrate that male, but not female, heterozygous Nf1 ± microglia exhibit differences in protein expression, which largely reflect pathways involved in cytoskeletal organization. In keeping with these predicted defects in cytoskeletal function, only male Nf1 ± microglia had reduced process arborization and surveillance capacity. To determine whether these microglial defects were cell autonomous or reflected adaptive responses to Nf1 heterozygosity in other cells in the brain, we generated conditional microglia Nf1-mutant knockout mice by intercrossing Nf1flox/flox with Cx3cr1-CreER mice (Nf1flox/wt; Cx3cr1-CreER mice, Nf1MG ± mice). Surprisingly, neither male nor female Nf1MG ± mouse microglia had impaired process arborization or surveillance capacity. In contrast, when Nf1 heterozygosity was generated in neurons, astrocytes and oligodendrocytes by intercrossing Nf1flox/flox with hGFAP-Cre mice (Nf1flox/wt; hGFAP-Cre mice, Nf1GFAP ± mice), the microglia defects found in Nf1 ± mice were recapitulated. Collectively, these data reveal that Nf1 ± sexually dimorphic microglia abnormalities are likely not cell-intrinsic properties, but rather reflect a response to Nf1 heterozygosity in other brain cells.


  • Open Access

    Microglia sense neuronal activity via GABA in the early postnatal hippocampus

    by Francesca Logiacco, Pengfei Xia, Svilen Veselinov Georgiev, Celeste Franconi, Yi-Jen Chang, Bilge Ugursu, Anje Sporbert, Ralf Kühn, Helmut Kettenmann, Marcus Semtner


  • Open Access

    Histamine triggers microglial responses indirectly via astrocytes and purinergic signaling

    by Pengfei Xia, Francesca Logiacco, Yimin Huang, Helmut Kettenmann, Marcus Semtner

    Histamine is a monoaminergic neurotransmitter which is released within the entire brain from ascending axons originating in the tuberomammillary nucleus in a sleep state‐dependent fashion. Besides the modulation of neuronal firing patterns, brain histamine levels are also thought to modulate functions of glial cells. Microglia are the innate immune cells and professional phagocytes of the central nervous system, and histamine was previously shown to have multiple effects on microglial functions in health and disease. Isolated microglia respond only to agonists of the Hrh2 subtype of histamine receptors (Hrh), and the expression of that isoform is confirmed by a metadata analysis of microglia transcriptomes. When we studied the effect of the histamine receptor isoforms in cortical and thalamic microglia by in situ live cell Ca2+ imaging using a novel, microglia‐specific indicator mouse line, microglial cells respond to external histamine application mainly in a Hrh1‐, and to a lower extent also in a Hrh2‐dependent manner. The Hrh1 response was sensitive to blockers of purinergic P2ry12 receptors, and since Hrh1 expression was predominantly found in astrocytes, we suggest that the Hrh1 response in microglia is mediated by astrocyte ATP release and activation of P2ry12 receptors in microglia. Histamine also stimulates microglial phagocytic activity via Hrh1‐ and P2ry12‐mediated signaling. Taken together, we provide evidence that histamine acts indirectly on microglial Ca2+ levels and phagocytic activity via astrocyte histamine receptor‐controlled purinergic signaling.


  • Open Access

    Neurofibromatosis 1 - Mutant microglia exhibit sexually-dimorphic cyclic AMP-dependent purinergic defects

    by Nirmeen Elmadany, Francesca Logiacco, Alice Buonfiglioli, Verena C. Haage, Elizabeth C. Wright-Jin, Alexander Schattenberg, Roxane M. Papawassiliou, Helmut Kettenmann, Marcus Semtner, David H. Gutmann


  • Open Access

    The VGF-derived Peptide TLQP21 Impairs Purinergic Control of Chemotaxis and Phagocytosis in Mouse Microglia

    by Nirmeen Elmadany, Felipe de Almeida Sassi, Stefan Wendt, Francesca Logiacco, Josien Visser, Verena Haage, Daniel Perez Hernandez, Philipp Mertins, Dolores Hambardzumyan, Susanne Wolf, et al.

    Microglial cells are considered as sensors of brain pathology by detecting any sign of brain lesions, infections, or dysfunction and can influence the onset and progression of neurological diseases. They are capable of sensing their neuronal environment via many different signaling molecules, such as neurotransmitters, neurohormones and neuropeptides. The neuropeptide VGF has been associated with many metabolic and neurological disorders. TLQP21 is a VGF-derived peptide and has been shown to signal via C3aR1 and C1qBP receptors. The effect of TLQP21 on microglial functions in health or disease is not known. Studying microglial cells in acute brain slices, we found that TLQP21 impaired metabotropic purinergic signaling. Specifically, it attenuated the ATP-induced activation of a K+conductance, the UDP-stimulated phagocytic activity, and the ATP-dependent laser lesion-induced process outgrowth. These impairments were reversed by blocking C1qBP, but not C3aR1 receptors. While microglia in brain slices from male mice lack C3aR1 receptors, both receptors are expressed in primary cultured microglia. In addition to the negative impact on purinergic signaling, we found stimulating effects of TLQP21 in cultured microglia, which were mediated by C3aR1 receptors: it directly evoked membrane currents, stimulated basal phagocytic activity, evoked intracellular Ca2+transient elevations, and served as a chemotactic signal. We conclude that TLQP21 has differential effects on microglia depending on C3aR1 activation or C1qBP-dependent attenuation of purinergic signaling. Thus, TLQP21 can modulate the functional phenotype of microglia, which may have an impact on their function in health and disease.SIGNIFICANCE STATEMENTThe neuropeptide VGF and its peptides have been associated with many metabolic and neurological disorders. TLQP21 is a VGF-derived peptide that activates C1qBP receptors, which are expressed by microglia. We show here, for the first time, that TLQP21 impairs P2Y-mediated purinergic signaling and related functions. These include modulation of phagocytic activity and responses to injury. As purinergic signaling is central for microglial actions in the brain, this TLQP21-mediated mechanism might regulate microglial activity in health and disease. We furthermore show that, in addition to C1qBP, functional C3aR1 responses contribute to TLQP21 action on microglia. However, C3aR1 responses were only present in primary cultures but notin situ, suggesting that the expression of these receptors might vary between different microglial activation states.


  • Open Access

    S-sulfocysteine/NMDA receptor–dependent signaling underlies neurodegeneration in molybdenum cofactor deficiency

    by Avadh Kumar, Borislav Dejanovic, Florian Hetsch, Marcus Semtner, Debora Fusca, Sita Arjune, Jose Angel Santamaria-Araujo, Aline Winkelmann, Scott Ayton, Ashley I. Bush, et al.

    Molybdenum cofactor deficiency (MoCD) is an autosomal recessive inborn error of metabolism characterized by neurodegeneration and death in early childhood. The rapid and progressive neurodegeneration in MoCD presents a major clinical challenge and may relate to the poor understanding of the molecular mechanisms involved. Recently, we reported that treating patients with cyclic pyranopterin monophosphate (cPMP) is a successful therapy for a subset of infants with MoCD and prevents irreversible brain damage. Here, we studied S-sulfocysteine (SSC), a structural analog of glutamate that accumulates in the plasma and urine of patients with MoCD, and demonstrated that it acts as an N-methyl D-aspartate receptor (NMDA-R) agonist, leading to calcium influx and downstream cell signaling events and neurotoxicity. SSC treatment activated the protease calpain, and calpain-dependent degradation of the inhibitory synaptic protein gephyrin subsequently exacerbated SSC-mediated excitotoxicity and promoted loss of GABAergic synapses. Pharmacological blockade of NMDA-R, calcium influx, or calpain activity abolished SSC and glutamate neurotoxicity in primary murine neurons. Finally, the NMDA-R antagonist memantine was protective against the manifestation of symptoms in a tungstate-induced MoCD mouse model. These findings demonstrate that SSC drives excitotoxic neurodegeneration in MoCD and introduce NMDA-R antagonists as potential therapeutics for this fatal disease.


  • Open Access

    Spontaneous Ca2+ transients in mouse microglia

    by Laura Korvers, Amanda de Andrade Costa, Martin Mersch, Vitali Matyash, Helmut Kettenmann, Marcus Semtner


  • Open Access

    Electrophysiological Signature of Homomeric and Heteromeric Glycine Receptor Channels

    by Constanze Raltschev, Florian Hetsch, Aline Winkelmann, Jochen C. Meier, Marcus Semtner


  • Open Access

    Chloride transporter KCC2-dependent neuroprotection depends on the N-terminal protein domain

    by A Winkelmann, M Semtner, J C Meier

    Neurodegeneration is a serious issue of neurodegenerative diseases including epilepsy. Downregulation of the chloride transporter KCC2 in the epileptic tissue may not only affect regulation of the polarity of GABAergic synaptic transmission but also neuronal survival. Here, we addressed the mechanisms of KCC2-dependent neuroprotection by assessing truncated and mutated KCC2 variants in different neurotoxicity models. The results identify a threonine- and tyrosine-phosphorylation-resistant KCC2 variant with increased chloride transport activity, but they also identify the KCC2 N-terminal domain (NTD) as the relevant minimal KCC2 protein domain that is sufficient for neuroprotection. As ectopic expression of the KCC2-NTD works independently of full-length KCC2-dependent regulation of Cl− transport or structural KCC2 C-terminus-dependent regulation of synaptogenesis, our study may pave the way for a selective neuroprotective therapeutic strategy that will be applicable to a wide range of neurodegenerative diseases.